February 24, 2016
Corporate

For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

Daiichi Sankyo Appoints New Group Corporate Officers

TOKYO, Japan (February 24, 2016) – Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2016.

 

1. DAIICHI SANKYO CO., LTD.

Name

Current Responsibilities

New Responsibilities

Yuki Sato

Representative Director

Member of the Board

Executive Vice President, Head of General Affairs & Human Resources Div.

Representative Director

Member of the Board

Takeshi Ogita

Member of the Board

Senior Executive Officer in charge of Vaccine Business

Member of the Board

Sunao Manabe

Member of the Board

Senior Executive Officer in charge of Global Sales & Marketing

Member of the Board

Executive Vice President

Head of General Affairs & Human Resources Div. and Head of Medical Affairs Div.

Katsumi Fujimoto

Executive Officer

Head of Supply Chain Div. and Vice President of Supply Chain Technology & Procurement Dept.

Senior Executive Officer

Head of Supply Chain Div.

Toshiaki Tojo

Executive Officer

Head of Quality and Safety Management Div.

Senior Executive Officer in charge of Vaccine Business

Satoru Kimura

Executive Officer

Head of Sales & Marketing Div.

Senior Executive Officer

Head of Sales & Marketing Div.

Ryoji Nagasaka

Corporate Officer

Vice President of Secretariat Dept.

Executive Officer

Vice President of Secretariat Dept.

Junichi Koga

Corporate Officer

Vice President of Biologics Function, R&D Div.

Executive Officer

Head of R&D Div. and Vice President of Research Technology Function, and in charge of Biologics

Koichi Akahane

Corporate Officer

Head of R&D Div. and Vice President of R&D Planning Dept.

Executive Officer

Vice President of Oncology Function, R&D Div.

Kohei Wada

Corporate Officer

Vice President of Development Function, and Clinical Execution Dept., R&D Div.

Corporate Officer

Vice President of Development Function,

R&D Div.

Kentaro Takamura

Vice President of Finance & Accounting Dept., Corporate Management Div.

Corporate Officer

Vice President of Finance & Accounting Dept.,

Corporate Management Div.

Ryoichi Watanabe

Vice President of Internal Audit Dept.

Corporate Officer

Vice President of Internal Audit Dept.

Junichi Fukute

Vice President of Supply Chain Planning Dept., Supply Chain Div.

Corporate Officer

Vice President of Supply Chain Planning Dept., Supply Chain Div.

Kenji Katsumi

Vice President of Corporate Business Management Dept., Corporate Management Div.

Corporate Officer

Vice President of Corporate Business Management Dept., Corporate Management Div.

Kentaro Murakawa

Vice President of Tokai Branch, Sales & Marketing Div.

Corporate Officer

Vice President of Tokyo Branch, Sales & Marketing Div.

Hirosumi Izawa

Vice President of Post-Marketing Regulatory Affairs Dept., Quality & Safety Management Div.

Corporate Officer

Head of Quality & Safety Management Div.

 


2. DAIICHI SANKYO HEALTHCARE CO., LTD.

Name

Current Responsibilities

New Responsibilities

Katsuhiko Yoshida

Member of the Board

Executive Officer in charge of Corporate Planning and Corporate Administration

Member of the Board

Senior Executive Officer in charge of Corporate Planning and Corporate Administration and R&D

Yasuhiro Kawanaka

Member of the Board

Corporate Officer

Vice President of Sales Administration Dept.

Member of the Board

Executive Officer

Vice President of Sales Administration Dept.

 

3. KITASATO DAIICHI SANKYO VACCINE CO., LTD.

Name

Current Responsibilities

New Responsibilities

Toshiaki Tojo

Executive Officer

Head of Quality & Safety Management Div., DAIICHI SANKYO CO., LTD.

President

Setsuo Arai

Member of the Board

Executive Vice President in charge of Quality Management and Quality & Safety Management

Member of the Board

* Takeshi Ogita (current President) will retire on March 31, 2016.